JENNIFER FIGUEROA: Open Payments
NPI 1720239585 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 17 payments from 8 companies in 2025. Trend: 2023 $222 · 2024 $498 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $114 |
| ABBVIE INC. | 5 | $84 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Celgene Corporation | 1 | $17 |
| Braintree Laboratories, Inc. | 1 | $14 |
Products named: TREMFYA, IMBRUVICA, VOWST, EMBLAVEO, XIFAXAN, OPDIVO, ENTYVIO, REBLOZYL.
Industry payments across NJ — which companies pay providers there.
